Wirksamkeit und Sicherheit der sublingualen Immuntherapie

Literatur

• 1 Noon L. Prophylactic inoculation against hay fever.  Lancet. 1911;  i 1572-1573
• 2 Frankland A W, Augustin R. Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isoled main protein components.  Lancet. 1954;  i 1055-1057
• 3 Lüderitz-Püchel U, Keller-Stanislawski B, Haustein D. Neubewertung des Risikos von Test- und Therapieallergenen.  Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2001;  7 709-718
• 4 Holt P G, Sly P D. Emerging concepts of T cell regulation in asthma and allergy.  Allergy Clin Immunol Int. 2003;  15 255-260
• 5 Secrist H, Chelen C J, Wen Y. et al . Allergen immunotherapy decreases IL-4 production in CD4⁺ T cells from allergic individuals.  J Exp Med. 1993;  178 2123-2130
• 6 Marcucci F, Sensi L, Di Cara G. et al .Dose dependence of immunological response to sublingual immunotherapy. Eingereicht bei Allergy
• 7 Noirey N, Rougier N, André C. et al . Langerhans-like dendritic cells generated from cord blood progenitors internalise pollen allergens by macropinocytosis, and part of the molecules are processed and can activate autologous naïve T-lymphocytes.  Clin Allergy. 2000;  13 509-513
• 8 Hosken N A, Shibuya K, Heath A W. et al . The effect of antigen dose on CD4⁺ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model.  J Exp Med. 1993;  182 1579-1584
• 9 Scadding K, Brostroff J. Low dose sublingual immunotherapy in patients with allergic rhinitis due to house dust mite.  Clin Allergy. 1986;  16 483-491
• 10 Kägi M K, Wüthrich B. Die lokale allergenspezifische Immuntherapie. In: Schultze-Werninghaus G, Fuchs T, Bachert C, Wahn U (Hrsg.). Manuale allergologicum. Oberhaching: Dustri-Verlag 2004
• 11 Wilson D R, Torres Lima M, Durham S. Sublingual immunotherapy for allergic rhinitis. The Cochrane Library 2003 Issue 2
• 12 Vourdas D, Syrigou E, Potamianou P. et al . Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.  Allergy. 1998;  53 662-672
• 13 Pradalier A, Basset D, Claudel A. et al . Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis.  Allergy. 1999;  54 819-828
• 14 Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis.  Allergy. 1998;  53 493-498
• 15 Bousquet J, Scheinmann P, Guinnepain M T. et al . Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.  Allergy. 1999;  54 249-260
• 16 Passalacqua G, Puccinelli P, Parmiani S. et al . Clinical and immunologic effect of a rush sublingual immunotherapy to Parietaria species: a double-blind, placebo-controlled trial.  J Allergy Clin Immunol. 1999;  104 964-968
• 17 André C, Vatrinet C, Galvain S. et al . Safety of sublingual-swallow immunotherapy in children and adults.  Int Arch Allergy Immunol. 2000;  121 229-234
• 18 Khinchi M S, Poulsen L K, Carat F. et al . Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled double-blind, double-dummy study.  Allergy. 2004;  59 45-53
• 19 Di Rienzo V, Marcucci F, Puccinelli P. et al . Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study.  Clin Exp Allergy. 2003;  33 206-210